期刊文献+
共找到1,023篇文章
< 1 2 52 >
每页显示 20 50 100
Exogenous lipoid pneumonia associated with nasal decongestants use: A narrative review of an under recognized clinical entity
1
作者 Abdul Basit Tehreem Kiran +2 位作者 Fnu Shaista Muneeb Saifullah Abdul M Basil 《World Journal of Respirology》 2025年第1期1-5,共5页
Exogenous lipoid pneumonia is a rare and under recognized pulmonary disorder caused by the inhalation or aspiration of fat-like substances.Nasal decongestants containing mineral oils or paraffin are emerging as overlo... Exogenous lipoid pneumonia is a rare and under recognized pulmonary disorder caused by the inhalation or aspiration of fat-like substances.Nasal decongestants containing mineral oils or paraffin are emerging as overlooked etiological agents.This review consolidates existing literature to delineate the clinical,radiological,and pathological features of exogenous lipoid pneumonia induced by nasal decongestants,highlight diagnostic challenges,and underscore the importance of thorough patient history in early diagnosis and management.This condition,while preventable,can result in serious pulmonary complications if not recog-nized early.It necessitates a multidisciplinary approach that incorporates careful history taking,high-resolution imaging,cytological assessment,and public health vigilance. 展开更多
关键词 lipoid pneumonia Nasal decongestants Pulmonology Respiratory medicine INFECTIONS
暂未订购
Preparation and characterization of a lipoid adsorption material and its atrazine removal performance 被引量:1
2
作者 Zhiqiang Chen Qinxue Wen +1 位作者 Jiaxiang Lian Nanqi Ren 《Journal of Environmental Sciences》 SCIE EI CAS CSCD 2011年第8期1293-1298,共6页
A novel adsorbent named lipold adsorption material (LAM), with a hydrophoblc nucleolus (trlolem) and a hydrophlllc membrane structure (polyamide), was synthesized to remove hydrophobic organic chemicals (HOCs)... A novel adsorbent named lipold adsorption material (LAM), with a hydrophoblc nucleolus (trlolem) and a hydrophlllc membrane structure (polyamide), was synthesized to remove hydrophobic organic chemicals (HOCs) from solution. Triolein, a type of lipoid, was entrapped by the polyamide membrane through an interfacial polymerization reaction. The method of preparation and the structure of the LAM were investigated and subsequent experiments were conducted to determine the characteristics of atrazine (a type of HOC) removal from wastewater using LAM as the adsorbent. The results showed that LAM had a regular structure compared with the prepolymer, where compact particles were linked with each other and openings were present in the structure of the LAM in which the fat drops formed from triolein were entrapped. In contrast to the atrazine adsorption behavior of powdered activated carbon (PAC), LAM showed a persistent adsorption capacity for atrazine when initial concentrations of 0.57, 1.12, 8.31 and 19.01 mg/L were present, and the equilibrium time was 12 hr. Using an 8 mg/L initial concentration of atrazine as an indicator of HOCs in aqueous solution, experiments on the adsorption capacity of the LAM showed 69.3% removal within 6-12 hr contact time, which was close to the 75.5% removal of atrazine by PAC. Results indicated that LAM has two atrazine removal mechanisms, namely the bioaccumulation of atrazine by the nucleous material and physical adsorption to the LAM membrane. Bioaccumulation was the main removal mechanism. 展开更多
关键词 lipoid adsorption material ATRAZINE powdered activated carbon
原文传递
Study of Interference Treatment by Xuesaitong (血塞通) Soft Capsuleon Patients of Nephrosis Syndrome with Qi Deficiency and Blood Stasisduring Dose Reducing Stage of Corticosteroid 被引量:1
3
作者 吕勇 王亿平 张莉 《Chinese Journal of Integrated Traditional and Western Medicine》 2004年第3期203-207,共5页
Objective: To observe the effect of Xuesaitong (血塞通, XST) soft capsule in interference treatment on patients of nephrosis syndrome (NS) during corticosteroid (CS) dose reducing stage. Methods: Seventy-one NS patien... Objective: To observe the effect of Xuesaitong (血塞通, XST) soft capsule in interference treatment on patients of nephrosis syndrome (NS) during corticosteroid (CS) dose reducing stage. Methods: Seventy-one NS patients applying prednisone and initiating dose reducing stage were randomized into trial group and control group. On the basis of conventional prednisone dose reduction of both groups, the trial group was given additionally XST, and the treatment course ended with the reduction to maintenance dose. In the course of observation, those who did not comply with the criteria of observation were excluded. Before and after the dose reduction, TCM syndrome scoring, 24 hrs urinary protein amount, blood β2-microglobulin (β2-MG), urinary β2-MG, blood fibrinogen (Fbg), plasma prothrombin time (PT), blood lipid, etc. were observed. Results: The trial group of XST could obviously lower their urinary protein amount and blood lipid level (P<0.05 or P<0.01), markedly improve the blood coagulation parameters (P<0.01), improve the TCM syndrome and CS induced adverse reaction (P<0.05 or P<0.01), also obviously reduced the recurrence rate of NS (P<0.05). Conclusion: XST could obviously improve the clinical symptoms and renal impairment parameters in NS patients during CS dose reduction stage, improve the CS induced adverse reaction and prevent the recurrence of NS. 展开更多
关键词 nephrosis syndrome CORTICOSTEROID qi deficiency and blood stasis Xuesaitong soft capsule
暂未订购
miRNAs Expression and Role of Dicer on Podocyte Injury in PAN Nephrosis Rats 被引量:1
4
作者 Chunqing Li Wei Sun +4 位作者 Haochang Du Dong Zhou Jihong Chen Lu Zhang Jiade Shao 《Chinese Medicine》 2015年第1期13-19,共7页
Objective: microRNAs (miRNAs) are regulatory RNAs that act as important players in diverse biologic and pathologic processes. Under circumstance as podocye-injury triggering proteinuria, which miRNAs are up-regulated ... Objective: microRNAs (miRNAs) are regulatory RNAs that act as important players in diverse biologic and pathologic processes. Under circumstance as podocye-injury triggering proteinuria, which miRNAs are up-regulated or down-regulated? This experiment aims at detecting miRNAs changes in PAN nephrosis rats based on miRNA arrays and exploring the therapeutic targets of Leizhi capsule. Methods: Fifty male wistar rats were randomly divided into five groups, including control group, model group, leizhi capsule group, Tripterygium glucosides group, and valsartan group. PAN nephrosis models were made by jugular vein injection of PAN (100 mg/kg body weight, dissolve in physiological saline), while control group rats were made by jugular vein injection of physiological saline with equal volume. Other groups rats had been given medicines by irrigating stomach once a day for ten days. Blood and urine samples were collected, and renal tissues were processed after rats being euthanasised. The 24 h urinary protein excretion and blood biochemistry parameters were measured by routine methods. The glomerular morphology and podocyte ultrastructure were observed with light microscopy and transmission electron microscopy respectively. miRNA expression profile was detected by Exiqon miRNA Array. Real time RT-PCR analysis for mature miRNAs was used to validate differentially expressed miRNAs. Results: 1) In day 3 - 5, model rats had decreased urine volume, ascites, malnutrition and wight loss. From day 7 to day 10, the nephrotic syndromes were worst in model rats, but which had no skin edema. Some rats died in serious ascites, the mortality is 3/10. 2) miRNA array detection shows 106 miRNAs up regulated and 62 miRNAs down regulated in PAN nephrosis rats. Fold change (model vs. control group) varies from 1.8 to 7.0. For leizhi capsule group and model sample, there are 90 miRNAs differentially expressed, with 65 miRNAs up and 25 miRNAs down. The most important finding in our research is the discovery of the specific miRNAs related to PAN nephrosis (rno-miR23a, rno-miR-24, rno-miR-30c and rno-miR-300-3p), which have been validated by Real time RT-PCR analysis. 3) Compared with control sample, immune fluorescence intensity of dicer, expression profile of nephrin, podocin and synaptopodin mRNA and protein decrease in PAN nephrosis rats. After treated with Leizhi Capsule, immune fluorescence intensity of the above molecules improved. Conclusion: 1) Characteristic miRNAs of PAN nephrosis were screening. Up-regulated miRNAs (rno-miR-23a, rno-miR-300-3p) may trigger podocyte injury and proteinuria, while down-regulated miRNAs (rno-miR-24, rno-miR-30c) may be protective factors by anti-apoptosis. 2) Dicer and these miRNAs (rno-miR-24, rno-miR-30c, rno-miR-23a) may be are probably key molecules therapeutic targets of Leizhi capsule. 展开更多
关键词 microRNAs PODOCYTE Injury PUROMYCIN Aminonucleoside nephrosis Model PROTEINURIA Leizhi CAPSULE
暂未订购
Congenital lipoid adrenal hyperplasia with Graves'disease:A case report 被引量:1
5
作者 Yan-Jun Wang Cong Liu +4 位作者 Chuan Xing Le Zhang Wan-Feng Xu Hai-Ying Wang Fu-Tao Wang 《World Journal of Clinical Cases》 SCIE 2022年第26期9390-9397,共8页
BACKGROUND Congenital adrenal hyperplasia(CAH),which is caused by a mutation of the steroidogenic acute regulatory(StAR)gene.Affected patients are usually characterized by adrenal insufficiency in the first year of li... BACKGROUND Congenital adrenal hyperplasia(CAH),which is caused by a mutation of the steroidogenic acute regulatory(StAR)gene.Affected patients are usually characterized by adrenal insufficiency in the first year of life,salt loss,glucocorticoid and mineralocorticoid deficiency,and female external genitalia,regardless of chromosomal karyotype.Patients with non-classical lipoid CAH usually develop glucocorticoid deficiency and mild mineralocorticoid deficiency at 2-4 years of age.CASE SUMMARY Herein,We report the case of a woman with non-classic lipoid CAH combined with Graves’disease.Her chromosome karyotype was 46,XX,and highthroughput sequencing revealed two missense variants in the StAR gene:c.229C>T(p.Q77X)and c.814C>T(p.R272C),which were inherited from both parents(non-close relatives).The patient was treated for Graves’disease in a timely manner and the dosage of glucocorticoid was adjusted during the treatment of Graves’disease.CONCLUSION This is the first case of non-classic lipoid CAH combined with Graves’disease reported in the Chinese population.In addition to conventional glucocorticoid replacement therapy,timely adjustments were made to the dosages of thyroid hormone and glucocorticoid to avoid adrenal crisis as a consequence of the increased demand and accelerated metabolism of glucocorticoids when the patient was diagnosed with Graves’disease. 展开更多
关键词 lipoid congenital adrenal hyperplasia Steroidogenic acute regulatory protein Adrenal insufficiency Graves’disease Case report
暂未订购
Lipoid Pneumonia Caused by Diesel Aspiration: A Case Report and Literature Review
6
作者 Fei Tian Fei Jiang +6 位作者 Xingguang Qu Jinglan Liu Shengmin Gui Liu Min Chaxiang Li Zhaohui Zhang Zuyang Xi 《Journal of Clinical and Nursing Research》 2023年第4期126-132,共7页
Diesel poisoning is a rare clinical condition.On September 27,2021,a 55-year-old male who mistakenly inhaled 20 mL of diesel through a siphon was admitted to our hospital.The main symptoms were cough and asthma.Chest ... Diesel poisoning is a rare clinical condition.On September 27,2021,a 55-year-old male who mistakenly inhaled 20 mL of diesel through a siphon was admitted to our hospital.The main symptoms were cough and asthma.Chest computed tomography(CT)showed both lungs scattered with patchy consolidation,ground-glass shadow,exudation,and pleural effusion.After 61 days of lung rehabilitation training and other supportive treatment,including oxygen therapy,postural drainage,ventilator support,bronchoalveolar lavage,hemoperfusion,continuous renal replacement therapy(CRRT),hormones,and antibiotics,the patient’s condition improved,and the patient was discharged.Through literature review,we found that lung consolidation,ground-glass shadow,nodular lesions,and pleural effusion can be observed on chest images of patients with lipoid pneumonia,with severe cases showing diffuse lesions involving both lungs,possibly secondary to respiratory failure.Children with acute critical illness deteriorates rapidly and have poor prognosis,whereas adults or patients with chronic poisoning have better prognosis after active treatment. 展开更多
关键词 Diesel poisoning Aspiration pneumonia lipoid pneumonia
暂未订购
Lipoid Proteinosis Due to Homozygous Nonsense Mutation in Extracellular Matrix Protein 1 Gene in 3 Pakistani Siblings
7
作者 Hira Tariq Shahbano Jawad +2 位作者 Shahbaz Aman Anjum Saeed Huma Arshad Cheema 《International Journal of Dermatology and Venereology》 2025年第2期114-116,共3页
Introduction:Urbach-Wiethe disease(or lipoid proteinosis)is an autosomal recessive genetic disease.It is caused by a mutation in the extracellular matrix protein 1 gene(ECM1),resulting in deposition of hyaline materia... Introduction:Urbach-Wiethe disease(or lipoid proteinosis)is an autosomal recessive genetic disease.It is caused by a mutation in the extracellular matrix protein 1 gene(ECM1),resulting in deposition of hyaline material at the dermoepidermal junction of the skin,around blood vessels,and at multiple other sites.Herein,we reported 3 siblings with lipoid proteinosis.Case presentation:The 3 siblings born to nonconsanguineous parents presented with hoarseness,macroglossia,yellow waxy skin,beaded papules on the eyelids,atrophic scars,and recurrent skin infections.Histopathologic examination showed hyaline deposition at the interface between the dermis and epidermis and at the basal lamina of blood vessels.Exome sequencing revealed a homozygous nonsense variant in ECM1.This variant created a premature stop codon,leading to loss of function.Both parents were heterozygous for the same mutation.Discussion:The gene responsible for lipoid proteinosis,ECM1,plays a key role in maintaining dermal homeostasis by influencing protein-protein binding and is also involved in aging and dermatoheliosis,which may explain the patients’prematurely aged appearance and dermal deposits in our cases.Lipoid proteinosis is rarely encountered in Pakistan.Around 47 variants of ECM1 have been documented,with about half involving exon 6 or 7 of the gene.The variant detected in our family was in exon 7.Genetic analysis and identification of causative variants may enhance understanding of the disease’s pathogenesis and aid better management.Conclusion:This report is a useful addition to the current knowledge base regarding this phenotypically and genetically variable genodermatosis,lipoid proteinosis,which is rarely reported in Pakistan. 展开更多
关键词 lipoid proteinosis HOMOZYGOUS nonsense mutation HETEROZYGOUS genetic analysis
原文传递
熊维建教授基于肾病三因论辨证论治儿童肾病综合征经验
8
作者 罗懿 熊维建 《中医临床研究》 2025年第11期105-109,共5页
儿童肾病综合征是临床常见的儿科疾病,其主要表现为大量的蛋白尿、低蛋白血症、高脂血症以及不同程度的水肿。目前,西医学治疗此病时面临主要问题包括患儿激素不敏感、激素依赖以及反复的蛋白尿,部分患儿甚至可发展为终末期肾脏病。中... 儿童肾病综合征是临床常见的儿科疾病,其主要表现为大量的蛋白尿、低蛋白血症、高脂血症以及不同程度的水肿。目前,西医学治疗此病时面临主要问题包括患儿激素不敏感、激素依赖以及反复的蛋白尿,部分患儿甚至可发展为终末期肾脏病。中医药的不断发展为临床治疗该病提供了更多的解决方法。儿童肾病综合征属于中医学中“水肿”“肾风”的范畴,诸多医家认为其病因、病机与肺、脾、肾三脏密切相关,国医大师郑新基于肾脏生理病理提出肾病三因论,即诸多肾脏疾病的发生发展都与肺、脾、肾三脏有关。熊维建教授,重庆市名中医,师从国医大师郑新20余载,传承国医大师郑新肾病三因论学术思想,临床治疗儿童肾病综合征以该理论为学术指导。熊维建教授认为小儿肺、脾、肾三脏不足,六淫犯肺,肺气被遏,脾不统水,肾失开阖,发为该病。疾病早期与肺气不足,易受外感相关,治疗时应该重视清肺利咽,防止疾病进展;疾病晚期,脾肾日益不足,水湿、血瘀等病理产物形成,复发亦与伏风、内风潜藏相关,以治肺补肾健脾为基本治法,辅以祛湿化瘀、祛风通络等治法,临床治疗儿童肾病综合征疗效确切。文章通过案例介绍熊维建教授应用肾病三因论辨证论治儿童肾病综合征,以期为临床治疗提供借鉴。 展开更多
关键词 儿童肾病综合征 肾病三因论 水肿
暂未订购
Novel Mutations in Extracellular Matrix Protein 1 Gene in a Chinese Patient with Lipoid Proteinosis 被引量:4
9
作者 Xiao Bai Jia-Wei Liu Dong-Lai Ma 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第22期2765-2766,共2页
Lipoid proteinosis (LP,OMIM 247100),also known as Urbach-Wiethe disease or lipoidosis cutis et mucosae,was first described by Urbach and Wiethe in 1929.It is a rare autosomal recessive genodermatosis characterized b... Lipoid proteinosis (LP,OMIM 247100),also known as Urbach-Wiethe disease or lipoidosis cutis et mucosae,was first described by Urbach and Wiethe in 1929.It is a rare autosomal recessive genodermatosis characterized by hoarseness from early infancy,distinctive skin and neurological manifestations,and cutaneous lesions.It affects mucosal membranes of the upper respiratory tract,upper digestive tract,central nervous system,lymph nodes,and striated muscles.Hamada identified the genetic defect to be a loss-of-function mutation or reduced expression of the gene encoding extracellular matrix protein 1 (ECM1) on chromosome lq21 in 2002.So far,approximately,300 cases have been reported.This article reported a case with clinical and molecular findings compatible with LP. 展开更多
关键词 Extracellular Matrix Protein 1 lipoid Protemosis MUTATION
原文传递
成人原发性微小病变型肾病综合征并发急性肾损伤的危险因素及对预后的影响
10
作者 虞亚环 王惠芳 +3 位作者 姜春晖 李先屹 孙越同 刘雪梅 《精准医学杂志》 2025年第4期342-347,共6页
目的分析成人原发性微小病变型肾病综合征(minimal change nephrotic syndrome,MCNS)并发急性肾损伤(acute kidney injury,AKI)的临床特点,并进一步探讨成人原发性MCNS并发AKI的危险因素及对预后的影响。方法收集青岛大学附属医院2013... 目的分析成人原发性微小病变型肾病综合征(minimal change nephrotic syndrome,MCNS)并发急性肾损伤(acute kidney injury,AKI)的临床特点,并进一步探讨成人原发性MCNS并发AKI的危险因素及对预后的影响。方法收集青岛大学附属医院2013年10月—2024年3月经肾穿刺活检确诊为成人原发性MCNS的患者315例,根据首次就诊时是否合并AKI分为MCNS组和MCNS+AKI组,分析成人MCNS合并AKI的临床特征,通过logistic回归模型分析成人原发性MCNS患者发生AKI的危险因素,并进一步分析成人原发性MCNS患者合并AKI对预后的影响。结果与MCNS组相比,MCNS+AKI组患者的年龄偏大(Z=3.989,P<0.05),男性多见(χ^(2)=7.623,P<0.05),血清补体C3、淋巴细胞计数、血红蛋白均较低(t=2.248~5.619,P<0.05),乳酸脱氢酶、血尿酸、尿红细胞计数、尿白细胞计数、D-二聚体、C反应蛋白、胱抑素C均较高(t=-3.292、-4.261,Z=2.492~5.973,P<0.05)。与MCNS组相比,MCNS+AKI患者肾脏组织病理改变中IgA沉积、发生肾间质病变及蛋白管型比例均较高(χ^(2)=4.567~12.013,P<0.05)。Logisitc回归分析显示,年龄≥60岁(OR=2.56,95%CI=1.10~5.95,P<0.05)、男性(OR=2.88,95%CI=1.36~6.11,P<0.05)、乳酸脱氢酶水平高(OR=1.00,95%CI=1.00~1.01,P<0.05)、血尿酸>385.04μmol/L(OR=1.98,95%CI=1.03~3.78,P<0.05)及蛋白管型(OR=2.73,95%CI=1.20~6.22,P<0.05)是成人原发性MCNS发生AKI的独立危险因素,而血红蛋白>139.26 g/L(OR=0.40,95%CI=0.20~0.80,P<0.05)是发生AKI的保护因素。相对于MCNS组,MCNS+AKI组患者尿蛋白完全缓解时长(t=2.318,P<0.05),其中MCNS+AKIⅡ期和Ⅲ期患者尿蛋白完全缓解时间显著长于MCNS+AKIⅠ期(F=3.287,t=2.080、2.048,P<0.05)。结论高龄、男性、血液中乳酸脱氢酶水平较高、高尿酸血症以及肾脏病理提示存在蛋白管型的成人原发性MCNS患者发生AKI的风险增高,临床上应加强监测此类患者的肾功能;AKI越严重的患者尿蛋白完全缓解需要的时间越长,AKI的早期识别和防治对成人原发性MCNS患者的预后具有重要意义。 展开更多
关键词 肾病 脂性 急性肾损伤 危险因素 乳酸脱氢酶类 高尿酸血症 蛋白管型 预后 成年人
暂未订购
不健康生活方式及吸烟与原发性膜性肾病的关系
11
作者 宋晨璐 亓晓菁 +1 位作者 陈怿鹏 邢广群 《临床荟萃》 2025年第6期513-518,共6页
目的本研究旨在探讨不健康生活方式和吸烟对原发性膜性肾病(primary membranous nephropathy,PMN)的影响。方法回顾性分析2016年10月-2023年3月在青岛大学附属医院首次诊断为PMN患者227例(PMN组)和微小病变肾病(minimal change nephropa... 目的本研究旨在探讨不健康生活方式和吸烟对原发性膜性肾病(primary membranous nephropathy,PMN)的影响。方法回顾性分析2016年10月-2023年3月在青岛大学附属医院首次诊断为PMN患者227例(PMN组)和微小病变肾病(minimal change nephropathy,MCD)患者58例(MCD组),所有患者均符合PMN或MCD的病理诊断标准。收集临床资料和问卷数据。另外,纳入其他5家医院2023年1-3月的问卷调查数据(PMN患者77例,MCD患者20例),组成多中心队列(PMN患者共304例,MCD患者共78例)。结果单中心和多中心两组男性、年龄、高血压史、收缩压、舒张压、高盐饮食、高脂饮食、频繁外出就餐(餐馆或外卖)、饮酒史和吸烟史差异均有统计学意义(P<0.05)。在多中心中,两组吸烟累积时间、每日吸烟量和吸烟指数占比差异均有统计学意义(P<0.05),PMN组糖尿病病史、进食夜宵和丰盛晚餐占比均较高(P<0.05)。虽然PMN组胆固醇各项指标皆低于MCD组,但血清氧化低密度脂蛋白和丙二醛水平更高,过氧化氢酶水平更低(P<0.05)。结论不健康的生活方式和吸烟可能参与PMN的发生,并可能产生较高的氧化应激状态。 展开更多
关键词 肾小球肾炎 膜性 肾病 脂性 饮食偏好 吸烟 氧化应激
暂未订购
左心房容积/机械耦合指数预测慢性肾脏病患者左心房功能受损
12
作者 姬莉芹 肖为为 +5 位作者 高雪 李厚钰 邹安灵子 张心茹 苗茁勐 于绍梅 《中国医学影像技术》 北大核心 2025年第5期733-738,共6页
目的观察左心房容积/机械耦合指数(LACI)预测慢性肾脏病(CKD)患者左心房(LA)功能受损的价值。方法回顾性收集213例CKD(CKD组)及50名健康人(对照组),比较组间临床资料、实验室指标及超声心动图参数;根据LACI四分位数值将CKD组分为4个亚组... 目的观察左心房容积/机械耦合指数(LACI)预测慢性肾脏病(CKD)患者左心房(LA)功能受损的价值。方法回顾性收集213例CKD(CKD组)及50名健康人(对照组),比较组间临床资料、实验室指标及超声心动图参数;根据LACI四分位数值将CKD组分为4个亚组,对比亚组间临床、实验室指标及超声心动图参数,分析LACI与心肌损伤实验室标志物及超声心动图参数的相关性。以LAVI>34 ml/m 2为LA功能受损,评估LACI、LA应变及LA僵硬指数(LASI)预测CKD患者LA功能受损的效能。结果组间性别、血压、肌酐、肾小球滤过率估计值(eGFR)、肌钙蛋白T(cTnT)、肌酸激酶同工酶(CK-MB)、N末端脑钠肽原(NT-proBNP)差异均有统计学意义(P均<0.05)。随LACI升高,CKD组内各亚组血压和糖尿病患病率、cTnT及NT-proBNP水平均呈升高趋势而eGFR呈降低趋势。LACI与cTnT、CK-MB、NT-proBNP及多个超声心动图参数均相关(P均<0.001)。以LACI预测CKD患者LA功能受损的AUC为0.884,高于LA储备期、管道期、收缩期应变及LASI(AUC=0.652、0.621、0.611、0.746,P均<0.05)。结论利用LACI可有效预测CKD患者LA功能受损。 展开更多
关键词 肾病 超声心动描记术 心房功能
暂未订购
微炎症指标联合NLR检测对行维持性血液透析的终末期肾病患者预后的评估价值
13
作者 方庆柏 田霞 《医学临床研究》 2025年第3期423-425,429,共4页
【目的】探讨微炎症指标联合中性粒细胞与淋巴细胞比值(NLR)对行维持性血液透析(MHD)的终末期肾病(ESRD)患者预后的评估价值。【方法】对行MHD的76例ESRD患者,随访1年,统计患者的预后情况,并据此分为预后不良组(A组,18例)和预后良好组(B... 【目的】探讨微炎症指标联合中性粒细胞与淋巴细胞比值(NLR)对行维持性血液透析(MHD)的终末期肾病(ESRD)患者预后的评估价值。【方法】对行MHD的76例ESRD患者,随访1年,统计患者的预后情况,并据此分为预后不良组(A组,18例)和预后良好组(B组,58例),分析影响患者预后的相关因素及微炎症指标联合NLR检测对患者预后的评估效能。【结果】76例患者,预后不良发生率为23.68%(18/76)。A组营养不良占比、感染占比、透析龄、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)及NLR均高于B组(P<0.05),A组残肾滤过率低于B组(P<0.05)。患者预后的独立影响因素包括残肾滤过率、hs-CRP及NLR(均P<0.05)。hs-CRP、NLR单一及联合预测行MHD的ESRD患者的灵敏度分别为72.22%、83.33%、66.67%,特异度为72.41%、65.52%、98.28%,联合诊断特异度高于单一诊断(P<0.05)。【结论】hs-CRP、NLR预测行MHD的ESRD患者预后的效能较好。 展开更多
关键词 肾病 肾透析 炎症趋化因子类 比值比 淋巴细胞 中性白细胞 预后
原文传递
乌司他丁防治老年冠心病合并慢性肾脏病患者对比剂诱导的急性肾损伤的临床研究 被引量:3
14
作者 李影 沈建 +4 位作者 张昕 周伯宁 焦阳 刘赫男 付振虹 《中华老年心脑血管病杂志》 CAS 北大核心 2024年第2期155-158,共4页
目的探究乌司他丁对老年冠心病合并慢性肾脏病(CKD)患者发生对比剂诱导的急性肾损伤(CIAKI)的防治作用。方法连续入选2021年11月至2022年11月解放军总医院第一医学中心收治的老年冠心病合并CKD并拟行冠状动脉造影的患者321例,分为乌司... 目的探究乌司他丁对老年冠心病合并慢性肾脏病(CKD)患者发生对比剂诱导的急性肾损伤(CIAKI)的防治作用。方法连续入选2021年11月至2022年11月解放军总医院第一医学中心收治的老年冠心病合并CKD并拟行冠状动脉造影的患者321例,分为乌司他丁组161例,水化组160例。比较2组术前及术后2 d心、肾功能指标,观察2组心、肾功能变化差异及CIAKI发生情况。结果乌司他丁组术后2 d血清肌酐、尿素、胱抑素C、同型半胱氨酸、N末端B型钠尿肽前体水平显著低于水化组,估算肾小球滤过率水平显著高于水化组(P<0.01)。321例中有62例(19.3%)符合CIAKI诊断,乌司他丁组17例,水化组45例,乌司他丁组与水化组比较有显著差异(10.6%vs 28.1%,P<0.01)。乌司他丁组合并高血压、糖尿病、高脂血症及高尿酸血症的患者CIAKI发生率较水化组显著降低(P<0.01)。多因素logistic回归分析显示,乌司他丁是发生CIAKI的保护因素(OR=0.348,95%CI:0.180~0.673,P=0.001)。结论乌司他丁可改善老年冠心病合并CKD患者的肾功能,降低CIAKI发生风险。 展开更多
关键词 冠心病 肾病 急性肾损伤 造影剂 血管造影术 乌司他丁
暂未订购
利拉鲁肽对老年2型糖尿病患者经皮冠状动脉介入治疗后造影剂肾病及预后的影响 被引量:1
15
作者 刘晓罡 付乃宽 +2 位作者 邵独婧 张鹏 张宏 《中华老年心脑血管病杂志》 CAS 北大核心 2024年第7期759-763,共5页
目的 探讨利拉鲁肽对老年2型糖尿病(T2DM)患者经皮冠状动脉介入治疗(PCI)术后造影剂肾病(CIN)及预后的影响。方法 回顾性分析2021年1月至2022年6月于天津市胸科医院心内科行PCI的老年T2DM患者364例,根据既往是否使用利拉鲁肽分为利拉鲁... 目的 探讨利拉鲁肽对老年2型糖尿病(T2DM)患者经皮冠状动脉介入治疗(PCI)术后造影剂肾病(CIN)及预后的影响。方法 回顾性分析2021年1月至2022年6月于天津市胸科医院心内科行PCI的老年T2DM患者364例,根据既往是否使用利拉鲁肽分为利拉鲁肽组145例和对照组219例。收集2组患者一般临床资料并使用倾向性评分匹配法校正混杂因素,倾向性评分匹配后,共纳入患者220例,每组110例。比较匹配后2组PCI术前及术后48 h血清肌酐(Scr)、尿素(BUN)、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、高敏C反应蛋白(hs-CRP)、丙二醛(MDA)、超氧化物歧化酶(SOD)、B淋巴细胞瘤-2相关X蛋白/B淋巴细胞瘤2基因比值、半胱氨酸天冬氨酸蛋白酶9及CIN发病率的差异,并在出院后随访18个月。采用多因素logistic回归分析利拉鲁肽对CIN发生的影响,采用Kaplan-Meier生存曲线分析和log rank检验比较2组主要不良心血管事件(MACE)发生的差异。结果 利拉鲁肽组术后48 h Scr、BUN、NGAL、hs-CRP、MDA水平显著低于对照组,SOD水平显著高于对照组(P<0.05,P<0.01)。利拉鲁肽组术后48 h CIN发病率显著低于对照组(7.27%vs 16.36%,P<0.05)。多因素logistic回归分析显示,利拉鲁肽是老年T2DM患者发生CIN的独立保护因素(OR=0.341,95%CI:0.128~0.906,P=0.031)。中位随访时间14.75(12.60,16.33)个月,利拉鲁肽组MACE发生率显著低于对照组(log rank χ^(2)=5.656,P=0.017)。结论 利拉鲁肽可以减少老年T2DM患者PCI术后CIN及MACE的发生,可能与其抗炎、抗氧化应激作用有关。 展开更多
关键词 利拉鲁肽 糖尿病 2型 经皮冠状动脉介入治疗 造影剂 肾病 预后
暂未订购
可溶性肾素前体受体在多系统疾病中的研究进展
16
作者 李孟野 姜一农 《中国全科医学》 CAS 北大核心 2024年第18期2295-2300,共6页
既往关于肾素-血管紧张素-醛固酮系统(RAAS)的研究以在心血管、肾脏等疾病中发挥重要作用的肾素、肾素前体、肾素前体受体(PRR)为主,其中PRR的生理功能已被广泛研究。可溶性肾素前体受体(sPRR)是通过蛋白酶切割PRR的细胞外成分产生,并... 既往关于肾素-血管紧张素-醛固酮系统(RAAS)的研究以在心血管、肾脏等疾病中发挥重要作用的肾素、肾素前体、肾素前体受体(PRR)为主,其中PRR的生理功能已被广泛研究。可溶性肾素前体受体(sPRR)是通过蛋白酶切割PRR的细胞外成分产生,并分泌到细胞外空间,因此sPRR水平的变化有可能反映组织RAAS的变化,然而临床对sPRR的相关研究有限。近年来越来越多的研究证据表明,sPRR在多种病理生理过程中具有重要的生物学功能,因此本文总结了sPRR在心血管疾病、肾脏疾病、呼吸系统疾病、内分泌和代谢性疾病、妊娠并发症、癌症等方面的最新研究进展,认为sPRR可能是多种疾病的新型生物标志物,并对代谢性疾病等具有潜在的治疗效果。 展开更多
关键词 肾病 肾素 肾素-血管紧张素系统 心血管疾病 可溶性肾素前体受体 多系统疾病 综述
暂未订购
腹膜透析患者预后危险因素调查与护理方案的建立
17
作者 席建宏 《山西医药杂志》 CAS 2024年第13期974-978,共5页
目的探究腹膜透析患者影响预后结局因素,进而构建满足腹膜透析患者护理需求的护理方案,为探索更好的适宜新疆地区的腹膜透析患者护理方案提供参考依据。方法选取新疆某三级甲等医院2015年1月至2020年1月就诊的腹膜透析患者128例作为研... 目的探究腹膜透析患者影响预后结局因素,进而构建满足腹膜透析患者护理需求的护理方案,为探索更好的适宜新疆地区的腹膜透析患者护理方案提供参考依据。方法选取新疆某三级甲等医院2015年1月至2020年1月就诊的腹膜透析患者128例作为研究对象。根据随访结局不同,运用SPSS 22.0和R4.2软件将患者基本信息和护理评估指标设为变量进行统计分析及绘图。所有变量行单因素Lo-gistic回归分析,将P<0.05定为差异因素或临床认为有意义变量均纳入多因素Logistic回归分析。同时构建列线图,可视化研究结局及变量因素影响,进一步构建腹膜透析患者护理问题推荐表。结果单因素Logistic分析结果显示认知评分、生理评分、健康行为评分、心理社会评分是腹膜透析患者预后的危险因素(P<0.05)。多因素Logistic分析结果显示:生理评分[OR值(95%CI)=2.62(1.28,5.34),P=0.008]和心理社会评分[OR值(95%CI)=2.55(1.44,4.53),P=0.001]是患者预后相关因素。结论生理评分和心理社会评分是影响腹膜透析患者预后的独立危险因素,基于此要加强相关护理干预,持续改进护理方案。 展开更多
关键词 肾病 腹膜透析 预后结局 护理方案
暂未订购
老年终末期肾病血液透析患者接受药物洗脱支架置入治疗的临床特点和预后分析 被引量:3
18
作者 冯园园 刘行 +3 位作者 张雪 刘彤 Seung-Woon Rha 陈康寅 《中华老年心脑血管病杂志》 CAS 北大核心 2024年第5期485-489,共5页
目的评估终末期肾病(ESRD)血液透析对老年患者接受药物洗脱支架(DES)置入治疗预后的影响。方法回顾性连续选取2003年3月至2021年7月于韩国高丽大学附属九老医院行DES治疗的年龄>60岁的患者4219例,将估算肾小球滤过率≥15ml/(min·... 目的评估终末期肾病(ESRD)血液透析对老年患者接受药物洗脱支架(DES)置入治疗预后的影响。方法回顾性连续选取2003年3月至2021年7月于韩国高丽大学附属九老医院行DES治疗的年龄>60岁的患者4219例,将估算肾小球滤过率≥15ml/(min·1.73m^(2))且未接受透析治疗的4102例作为老年非ESRD组,接受透析治疗的117例作为老年ESRD组,依据2组患者基线资料建立倾向性评分匹配(PSM)模型,PSM后老年非ESRD组183例,老年ESRD组99例。随访1年、3年、5年,记录主要不良心血管事件(MACE)等临床终点事件,绘制Kaplan-Meier生存曲线,用PSM和多因素Cox回归验证临床终点事件。结果PSM前老年ESRD组合并高血压、糖尿病、外周血管疾病、其他诊断比例高于老年非ESRD组(P<0.01)。Cox单因素回归分析显示,老年ESRD是行DES置入患者术后1年、3年、5年发生全因死亡的危险因素(P<0.05,P<0.01);老年ESRD是行DES置入患者术后3年、5年发生MACE的危险因素(HR=2.67,95%CI:1.73~4.10,P=0.000;HR=2.65,95%CI:1.79~3.90,P=0.000);老年ESRD是行DES置入患者术后5年发生TVR、TLR、NTVR和血运重建的危险因素(P<0.05,P<0.01)。Kaplan-Meier生存曲线显示,老年ESRD组无MACE生存率降低(80.0%vs 90.2%,Plog rank=0.006)。结论ESRD显著增加老年DES置入患者术后长期MACE的风险。 展开更多
关键词 肾病 连续性肾替代疗法 药物洗脱支架 预后 预测 主要不良心血管事件
暂未订购
序贯血液透析滤过联合血液灌流模式对终末期肾病患者微炎症状及心血管结局的影响 被引量:10
19
作者 贾美荣 张梦雅 +4 位作者 张思源 张欢 陈烁 侯万萍 孔凌 《临床和实验医学杂志》 2024年第7期714-718,共5页
目的探究序贯血液透析滤过(HDF)联合血液灌流(HP)模式对终末期肾病(ESRD)患者微炎症状态以及心血管结局的影响。方法回顾性选取2021年6月至2023年6月在东部战区总医院、南京市六合人民医院、南京市南京医科大学第四附属医院收治的ESRD患... 目的探究序贯血液透析滤过(HDF)联合血液灌流(HP)模式对终末期肾病(ESRD)患者微炎症状态以及心血管结局的影响。方法回顾性选取2021年6月至2023年6月在东部战区总医院、南京市六合人民医院、南京市南京医科大学第四附属医院收治的ESRD患者86例,依据治疗方法不同将其分为普通血液透析(HD)组(n=25)、HDF组(n=30)以及HDF+HP组(n=31),3组均持续治疗3个月。比较3组治疗前、治疗3个月后患者微炎症状态指标[C反应蛋白(CRP)、白细胞介素(IL)-6、IL-8以及肿瘤坏死因子-α(TNF-α)]、营养指标(总蛋白、白蛋白、转铁蛋白、血红蛋白)以及钙磷代谢指标[甲状旁腺激素(iPTH)、血钙、血磷]水平的差异性,并统计患者心血管结局情况。结果治疗3个月后,HDF+HP组患者CRP、IL-6、IL-8、TNF-α、iPTH、血磷水平分别为(6.00±0.47)mg/L、(34.20±0.58)ng/mL、(17.00±1.58)ng/L、(37.25±1.20)ng/mL、(256.20±30.23)pg/L、(1.66±0.09)mmol/L,均低于HD组[(8.23±1.05)mg/L、(38.30±1.14)ng/mL、(25.13±4.00)ng/L、(42.23±1.25)ng/mL、(569.43±45.11)pg/L、(2.06±0.10)mmol/L],也低于HDF组[(7.61±0.85)mg/L、(36.00±1.00)ng/mL、(19.15±2.04)ng/L、(40.96±1.10)ng/mL、(380.69±23.10)pg/L、(1.90±0.11)mmol/L],差异均有统计学意义(P<0.05)。治疗3个月后,HDF+HP组患者总蛋白、白蛋白、转铁蛋白、血红蛋白以及血钙水平分别为(65.58±6.12)g/L、(39.74±5.00)g/L、(370.62±34.00)mg/dL、(110.15±7.30)g/L、(2.54±0.11)mmol/L,均高于HD组[(58.62±4.18)g/L、(31.67±3.67)g/L、(224.30±12.00)mg/dL、(94.90±3.15)g/L、(2.34±0.10)mmol/L],也高于HDF组[(62.00±5.47)g/L、(35.69±4.12)g/L、(304.15±23.68)g/L、(105.63±4.98)g/L、(2.40±0.10)mmol/L],差异均有统计学意义(P<0.05)。3组间心血管事件发生率比较,差异无统计学意义(P>0.05)。结论HDF联合HP模式可有效改善ESRD患者的微炎症状态与营养状况,调节其钙磷代谢,不会增加心血管事件风险,是一种安全且有效的杂合血液净化方法。 展开更多
关键词 肾病 血液透析滤过 血液灌流 微炎症状态 心血管结局
暂未订购
钠-葡萄糖协同转运蛋白2抑制剂在肥胖相关性肾病中的作用及机制 被引量:3
20
作者 叶勇健 顾俊菲 《中国临床保健杂志》 CAS 2024年第5期705-710,共6页
随着全球肥胖患病率的上升,与肥胖相关的多种疾病,特别是肾脏疾病的发病率也在上升。肥胖是慢性肾脏疾病的独立危险因素,肥胖相关性肾病的病理生理机制复杂,涉及肾小球血流动力改变、肾素-血管紧张素-醛固酮系统过度激活、胰岛素抵抗、... 随着全球肥胖患病率的上升,与肥胖相关的多种疾病,特别是肾脏疾病的发病率也在上升。肥胖是慢性肾脏疾病的独立危险因素,肥胖相关性肾病的病理生理机制复杂,涉及肾小球血流动力改变、肾素-血管紧张素-醛固酮系统过度激活、胰岛素抵抗、炎症反应及氧化应激等。钠-葡萄糖协同转运蛋白2抑制剂作为一种新型降血糖药物,已经被证实具有显著的肾脏获益。该文综述了肥胖相关性肾病的发病机制及钠-葡萄糖协同转运蛋白2抑制剂对其保护作用及机制。 展开更多
关键词 肾病 肥胖症 钠-葡萄糖转运体2
暂未订购
上一页 1 2 52 下一页 到第
使用帮助 返回顶部